Texas in the Front Row to Receive COVID-19 Vaccine

By Maria T. Morales

Doctors, nurses, older adults with chronic conditions, and those who live in nursing homes, will be the first to receive the COVID-19 vaccine in Texas.

So I announce, Greg Abbott, governor of Texas, and whose State will be one of the first to receive the first endowment due to the daily increase in infections that does not give truce.

This week, the Department of Health and Human Services, announced that, at the national level, will be distributed 40 millions of vaccines to face and stop the outbreak of the pandemic that, since the end of October there has been no truce in the American union.

The United States Drug and Drug Administration (FDA), by acronym in English, must give the green light to the vaccine, at least, the 10 December so that the 12 of the same month, the country can start with the application of the same.

Currently, Pfizer and Moderna laboratories await official approval for the use and distribution of the vaccine..

Like the mask, the one that for Abbott is not mandatory, the application of the vaccine will not be either.

“In Texas, no one will be forced to get the vaccine. It will always be voluntary ", expressed through his Twitter account.

Customers line up for Thanksgiving shopping. The outbreak of COVID-19 has caused many businesses to return, as at the beginning of the pandemic, to reduce the entry of customers to your facilities.

Antibody therapy for infected patients

The state official also announced that in El Paso, where the wave of infections reached the extreme, weeks ago, COVID-19 patients are treated with antibody therapy.

Early november, FDA issued "Emergency Use Authorization for Investigational Bamlanivimab Monoclonal Antibody Therapy".

According to the FDA, therapy for mild to moderate COVID-19 treatment, will apply to adult and pediatric patients of 12 years old and weighing, at least 40 kilograms (approximately 88 pounds).

Bamlanivimab is not authorized in critically ill hospitalized patients with COVID-19 who require oxygen therapy, since this could worsen the clinical results of patients, according to FDA report.